175 related articles for article (PubMed ID: 38433330)
1. Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.
Kaci A; Solheim MH; Silgjerd T; Hjaltadottir J; Hornnes LH; Molnes J; Madsen A; Sjøholt G; Bellanné-Chantelot C; Caswell R; Sagen JV; Njølstad PR; Aukrust I; Bjørkhaug L
Hum Mol Genet; 2024 May; 33(10):894-904. PubMed ID: 38433330
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoter-driven HNF4A-MODY diabetes.
Kind L; Molnes J; Tjora E; Raasakka A; Myllykoski M; Colclough K; Saint-Martin C; Adelfalk C; Dusatkova P; Pruhova S; Valtonen-André C; Bellanné-Chantelot C; Arnesen T; Kursula P; Njølstad PR
JCI Insight; 2024 Jun; 9(11):. PubMed ID: 38855865
[TBL] [Abstract][Full Text] [Related]
3. Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.
Guo S; Lu H
J Cell Biochem; 2019 Jan; 120(1):519-532. PubMed ID: 30191603
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
[TBL] [Abstract][Full Text] [Related]
6. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
7. Identification of HNF4A Mutation p.T130I and HNF1A Mutations p.I27L and p.S487N in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes.
Yang Y; Zhou TC; Liu YY; Li X; Wang WX; Irwin DM; Zhang YP
J Diabetes Res; 2016; 2016():3582616. PubMed ID: 26981542
[TBL] [Abstract][Full Text] [Related]
8. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A.
Stanescu DE; Hughes N; Kaplan B; Stanley CA; De León DD
J Clin Endocrinol Metab; 2012 Oct; 97(10):E2026-30. PubMed ID: 22802087
[TBL] [Abstract][Full Text] [Related]
9. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
10. A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry.
Raeder H; Bjørkhaug L; Johansson S; Mangseth K; Sagen JV; Hunting A; Følling I; Johansen O; Bjørgaas M; Paus PN; Søvik O; Molven A; Njølstad PR
Diabetes; 2006 Jun; 55(6):1899-903. PubMed ID: 16731861
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young.
Beijers HJ; Losekoot M; Odink RJ; Bravenboer B
Diabet Med; 2009 Nov; 26(11):1172-4. PubMed ID: 19929997
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
Ellard S; Colclough K
Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
[TBL] [Abstract][Full Text] [Related]
13. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E; Shaat N; Holst JJ
Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
[TBL] [Abstract][Full Text] [Related]
15. Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Karlsson E; Shaat N; Groop L
Diabet Med; 2008 Jul; 25(7):788-91. PubMed ID: 18513302
[TBL] [Abstract][Full Text] [Related]
16. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
[TBL] [Abstract][Full Text] [Related]
17. Functional Analyses of HNF1A-MODY Variants Refine the Interpretation of Identified Sequence Variants.
Malikova J; Kaci A; Dusatkova P; Aukrust I; Torsvik J; Vesela K; Kankova PD; Njølstad PR; Pruhova S; Bjørkhaug L
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32017842
[TBL] [Abstract][Full Text] [Related]
18. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies.
Carette C; Dubois-Laforgue D; Saint-Martin C; Clauin S; Beaufils S; Larger E; Sola A; Mosnier-Pudar H; Timsit J; Bellanné-Chantelot C
Diabet Med; 2010 Dec; 27(12):1454-8. PubMed ID: 21105491
[TBL] [Abstract][Full Text] [Related]
19. Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.
Sampathkumar G; Valiyaparambil PP; Kumar H; Bhavani N; Nair V; Menon U; Menon A; Abraham N; Chapla A; Thomas N
J Endocrinol Invest; 2022 Mar; 45(3):607-615. PubMed ID: 34741762
[TBL] [Abstract][Full Text] [Related]
20. HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of
Haque E; Teeli AS; Winiarczyk D; Taguchi M; Sakuraba S; Kono H; Leszczyński P; Pierzchała M; Taniguchi H
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
